Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis
2022 · American Journal of Hematology · 57 citations
https://doi.org/10.1002/ajh.26475
J
Jishi Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
259
Papers
3.4K
Citations
34
h-index
85
i10-index
Jishi Wang is an academic researcher from Guiyang Medical University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Heme Oxygenase-1 and Carbon Monoxide & Chronic Myeloid Leukemia Treatments. The author has an h-index of 34, co-authored 221 publications.
ORCID: 0009-0007-1053-6588Papers by this author
worksRituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study
2016 · BMC Cancer · 32 citations
https://doi.org/10.1186/s12885-016-2523-7
HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia
2019 · Journal of Translational Medicine · 21 citations
https://doi.org/10.1186/s12967-019-2115-9
Effect of Salinity on the Transformation of Wheat Straw and Microbial Communities in a Saline Soil
2017 · Communications in Soil Science and Plant Analysis · 19 citations
https://doi.org/10.1080/00103624.2017.1373787
Nuclear factor Nrf2 promotes glycosidase OGG1 expression by activating the AKT pathway to enhance leukemia cell resistance to cytarabine
2022 · Journal of Biological Chemistry · 19 citations
https://doi.org/10.1016/j.jbc.2022.102798
Identification of crucial genes and prediction of small molecules for multidrug resistance of Hodgkin’s lymphomas
2018 · Cancer Biomarkers · 7 citations
https://doi.org/10.3233/cbm-181496
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat